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Porcine epidemic diarrhea virus: An




The enteric disease of swine recognized in the early 1970s in Europe was initially described as “epidemic viral
diarrhea” and is now termed “porcine epidemic diarrhea (PED)”. The coronavirus referred to as PED virus (PEDV) was
determined to be the etiologic agent of this disease in the late 1970s. Since then the disease has been reported in
Europe and Asia, but the most severe outbreaks have occurred predominantly in Asian swine-producing countries.
Most recently, PED first emerged in early 2013 in the United States that caused high morbidity and mortality
associated with PED, remarkably affecting US pig production, and spread further to Canada and Mexico. Soon
thereafter, large-scale PED epidemics recurred through the pork industry in South Korea, Japan, and Taiwan. These
recent outbreaks and global re-emergence of PED require urgent attention and deeper understanding of PEDV
biology and pathogenic mechanisms. This paper highlights the current knowledge of molecular epidemiology,
diagnosis, and pathogenesis of PEDV, as well as prevention and control measures against PEDV infection. More
information about the virus and the disease is still necessary for the development of effective vaccines and control
strategies. It is hoped that this review will stimulate further basic and applied studies and encourage collaboration
among producers, researchers, and swine veterinarians to provide answers that improve our understanding of
PEDV and PED in an effort to eliminate this economically significant viral disease, which emerged or re-emerged
worldwide.
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Background
Historical perspective
In 1971, British veterinary clinicians noted the appear-
ance of a previously unrecognized enteric disease in
growing and fattening pigs [1]. A clinical presentation of
watery diarrhea was similar to symptoms of the porcine
transmissible gastroenteritis virus (TGEV) infection.
However, in the latter case, nursing piglets were only
mildly affected. The disease, named epidemic viral diar-
rhea (EVD), then spread to multiple swine-producing
countries in Europe. Five years later, TGE-like EVD re-
emerged and in contrast to previous outbreaks, the dis-
ease occurred in pigs of all ages including suckling pigs.
Therefore, EVD in 1976 was classified as EVD type 2 in
order to differentiate it from the initial EVD type 1 con-
dition [2, 3]. In 1978, scientists at the Ghent University
in Belgium were the first research group, which partially
fulfilled Koch’s postulates and described a coronavirus-
like agent (CV777) as the causative pathogen. Fur-
thermore, they provided evidence that this novel virus
was distinct from the two known porcine corona-
viruses, TGEV and hemaggultinating encephalomyeli-
tits virus [4, 5]. Since then, the EVD disease has been
known as “porcine epidemic diarrhea (PED)”.
Since the 1990s, PED cases have become rare in
Europe and PED virus (PEDV)-associated diarrhea has
been usually observed in adult pigs, whereas suckling
piglets were generally spared or developed only mild
symptoms [6]. PED was first reported in Asia in 1982
and since then it has had a great economic impact on
the Asian pork industry [7–11]. In contrast to the
present situation in Europe, PED epizootics in Asia are
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more severe causing high mortality in neonatal piglets
and the disease has become an endemic pattern recently.
However, despite a notorious reputation in Asian swine-
producing countries, PED was not a well-known disease
worldwide. For example, the disease had never occurred
in the United States until 2013. In May 2013, PED sud-
denly appeared in the United States and rapidly spread
across the country, as well as to Canada and Mexico,
causing deaths of more than 8 million newborn piglets
in the United States alone during a 1 year-epidemic
period [12–15]. Subsequently, severe PED outbreaks
recurred in Asian countries including South Korea,
Taiwan, and Japan [16–18]. PEDV has now emerged or
re-emerged as one of the most devastating viral diseases
of swine in the world, leading to significant financial
concerns in the global pork industry.
This paper is a brief review focusing on current under-
standing of the molecular biology, epidemiology, diagno-
sis, and pathogenesis of PEDV, as well as control
strategies to prevent PEDV infection.
Review
The virus
PEDV genome and virion structures
PEDV, the etiological agent of PED, is a large-enveloped
RNA virus, which is a member of the genus Alphacoro-
navirus within the Coronaviridae family placed with the
Arteriviridae family in the order Nidovirales on the basis
of similarities in genome organization and replication
strategy [4, 6, 19]. The PEDV genome is approximately
28 kb long with a 5’ cap and a 3’ polyadenylated tail and
comprises a 5’ untranslated region (UTR), at least 7
open reading frames (ORF1a, ORF1b, and ORF2–6), and
a 3’ UTR [20]. The two large ORFs 1a and 1b occupy
the 5’-proximal two-thirds of the genome coding for
nonstructural proteins (nsps). ORF1a translation yields a
replicase polyprotein (pp) la, whereas ORF1b is
expressed by a −1 ribosomal frame shift (RFS), which C-
terminally extends ppla into pp1ab. These ppla and
pplab are post-translationally cleaved by internal prote-
ases generating 16 processing end products, named
nsp1–16. The remaining ORFs in the 3’-proximal gen-
ome region encode four structural proteins expressed
from the respective 3’-co-terminal nested set of subge-
nomic (sg) mRNAs: the 150–220 kDa glycosylated spike
(S) protein, 20–30 kDa membrane (M) protein, 7 kDa
envelope (E) protein, 58 kDa nucleocapsid (N) protein,
and one accessory gene ORF3 (Fig. 1a) [6, 20–22].
The PEDV genome is encapsulated by a single N pro-
tein, forming a long and helical coil structure that is
wrapped in a lipid envelope containing 3 surface-
associated structural proteins, S, M, and E (Fig. 1b).
Enveloped virions are roughly spherical and pleomorphic
with a diameter ranging from 95 to 190 nm, including
the widely spaced, club-shaped, trimerized S projections
measuring 18–23 nm in length [4]. PEDV has a buoyant
density of 1.18 g/ml in sucrose and is sensitive to ether
and chloroform. The virus is stable at 4–50 °C and is ab-
solutely inactivated at pH values beyond pH 4–9 range
[23]. Therefore, PEDV is inactivated by various acidic or
alkaline disinfectants [24].
PEDV structural proteins
Among viral structural proteins, the S protein of PEDV
is the major envelope type I glycoprotein of the virion,
which interacts with the cellular receptor during virus
entry and stimulates induction of neutralizing antibodies
in the natural host [22, 25, 26]. In addition, it is associ-
ated with growth adaptation in vitro and attenuation in
vivo [27]. Thus, the PEDV S glycoprotein is known to be
an appropriate viral gene for determining the genetic
relatedness among PEDV isolates and for developing
diagnostic assays and effective vaccines [16, 26, 28–30].
The M protein, the most abundant component of the
viral envelope, is required for the assembly process and
can also elicit the production of protective antibodies
with virus-neutralizing activity [31, 32]. The small enve-
lope E protein plays an important role during corona-
virus budding, and coexpression of E and M proteins
can form spike-less coronavirus-like virions [33]. PEDV
E and N proteins are found in the endoplasmic
reticulum (ER) where they independently induce ER
stress [34, 35]. The N protein has multiple functions in
viral replication and pathogenesis in coronavirology [36].
Generally, N proteins of coronaviruses interact with viral
genomic RNA and associate with other N protein mole-
cules to protect the viral genome, serving as the critical
basis for the helical nucleocapsid during coronavirus as-
sembly [36]. The PEDV N protein also perturbs antiviral
responses by antagonizing interferon production, as part
of the immune evasion strategy, and activates NF-κB
[35, 37]. The product of ORF3, the only accessory gene
in PEDV, is thought to function as an ion channel and
to influence virus production and virulence [38, 39].
PEDV-host interactions
Coronaviruses can infect a wide range of mammals,
including humans, bats, and whales, and birds, but typic-
ally they have a limited host range, infecting only their
specific natural host. Furthermore, coronaviruses exhibit
a marked tropism for epithelial cells of the respiratory
and enteric tracts, as well as for macrophages [40–42].
PEDV also has a restricted tissue tropism and replicates
efficiently in porcine small intestinal villous epithelial
cells or enterocytes. Porcine aminopeptidase N (pAPN)
predominantly expressed on the surface of epithelial
cells of small intestine has been identified as the cellular
receptor for PEDV [43, 44]. The N-terminal region of
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the PEDV spike protein S1 domain is important for recog-
nizing the pAPN receptor [45]. Thus, PEDV entry begins
with the binding to pAPN followed by internalization of
the virus into target cells by direct membrane fusion, and
a subsequent release of the viral genome into the cytosol
after uncoating to start the genome replication (Fig. 2). In
addition to replicating in primary target cells from the nat-
ural host, PEDV can grow in some African green monkey
kidney cell lines (Vero and MARC-145) [46, 47]. Although
it still remains to be determined whether APN acts as the
functional receptor for PEDV on these cells, overexpres-
sion of exogenous pAPN renders non-permissive cells
susceptible to PEDV infection. This observation suggests
a functional significance of the APN receptor density for
PEDV propagation in cell culture [44]. A recent study also
revealed that cell-surface heparan sulfate acts as the
attachment factor of PEDV in Vero cells [48]. The
addition of trypsin is indispensable for the isolation and
serial passages in Vero cells [28, 46, 49, 50]. Trypsin facili-
tates PEDV entry and release by cleaving the S protein
into S1 and S2 subunits, enabling efficient viral replication
and spreading in vitro [51, 52]. However, some cell-
adapted attenuated PEDV strains, such as SM98-1 and
83P-5, can support PEDV propagation in the absence of
trypsin [44, 53]. As a result of viral infection, distinct cyto-
pathic effects (CPEs) including cell fusion, vacuolation,
syncytium, and detachment are produced in infected Vero
cells [49].
Since viruses are obligate intracellular parasites, they
may adjust the activity of cellular factors or signaling
pathways to benefit their own multiplication in host
cells. Proteome analysis showed that the expression of
proteins involved in apoptosis, signal transduction, and
stress responses is affected in PEDV-infected Vero cells
Fig. 1 Schematic representations of PEDV genome organization and virion structure. a The structure of PEDV genomic RNA. The 5’-capped and
3’-polyadenylated genome of approximately 28 kb is shown at the top. The viral genome is flanked by UTRs and is polycistronic, harboring
replicase ORFs 1a and 1b followed by the genes encoding the envelope proteins, the N protein, and the accessory ORF3 protein. S, spike; E,
envelope; M, membrane; N, nucleocapsid. Expression of the ORF1a and 1b yields two known polyproteins (pp1a and pp1ab) by −1 programmed
RFS, which are co-translationally or post-translationally processed into at least 16 distinct nsps designated nsp1–16 (bottom). PLpro, papain-like
cysteine protease; 3CLpro, the main 3C-like cysteine protease; RdRp; RNA-dependent RNA polymerase; Hel, helicase; ExoN, 3’→ 5’ exonuclease;
NendoU, nidovirus uridylate-specific endoribonuclease; 2’OMT, ribose-2’-O-methyltransferase. b Model of PEDV structure. The structure of the PEDV
virion is illustrated on the left. Inside the virion is the RNA genome associated with the N protein to form a long, helical ribonucleoprotein (RNP)
complex. The virus core is enclosed by a lipoprotein envelope, which contains S, E, and M proteins. The predicted molecular sizes of each structural
protein are indicated in parentheses. A set of corresponding sg mRNAs (sg mRNA; 2–6), through which canonical structural proteins or nonstructural
ORF3 protein are exclusively expressed via a co-terminal discontinuous transcription strategy, are also depicted on the right
Lee Virology Journal  (2015) 12:193 Page 3 of 16
[54]. PEDV induces apoptotic cell death in vitro and
in vivo through the caspase-independent mitochondrial
apoptosis-inducing factor (AIF) pathway [55]. PEDV in-
fection activates the three major mitogen-activated pro-
tein kinase (MAPK) cascades involving extracellular
signaling-regulated kinase (ERK), p38 MAPK, and c-Jun
N-terminal kinase (JNK) [55, 56] (Kim Y, Lee C, unpub-
lished data). In addition, PEDV appears to induce ER
stress and activate NF-κB [34, 35]. Therefore, viral repli-
cation and subsequent pathological changes rely on
PEDV ability to exploit multiple intracellular processes,
such as apoptosis, MAPK signaling, and ER stress, which
emerge in response to various extracellular stimuli.
Heterogeneity
Coronaviruses possess the largest known RNA genomes.
Nonetheless, they maintain the stability and high fidelity
replication of their large genomes while concomitantly
generating genetic diversity required for adaptation and
emergence. These properties can be ascribed to the 3’-
to-5’ proofreading exoribonuclease activity within nsp14
[57, 58]. Considering the high fidelity of coronavirus
Fig. 2 Overview of the PEDV replication cycle. PEDV binds pAPN via the spike protein. Penetration and uncoating occur after the S protein-mediated
fusion of the viral envelope with the plasma membrane. Following disassembly, the viral genome is released into the cytoplasm and immediately
translated to yield replicases ppla and pp1ab. These polyproteins are proteolytically cleaved into 16 nsps comprising the replication and transcription
complex (RTC) that first engages in the minus-strand RNA synthesis using genomic RNA. Both full- and sg-length minus strands are produced and
used to synthesize full-length genomic RNA and sg mRNAs. Each sg mRNA is translated to yield only the protein encoded by the 5’-most
ORF of the sg mRNA. The envelope S, E, and M proteins are inserted in the ER and anchored in the Golgi apparatus. The N protein interacts with
newly synthesized genomic RNA to form helical RNP complexes. The progeny virus is assembled by budding of the preformed RNP at the ER-Golgi
intermediate compartment (ERGIC) and then released by the exocytosis-like fusion of smooth-walled, virion-containing vesicles with the plasma
membrane [22]
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RNA replication, PEDV is assumed to undergo a slow
evolutionary process accumulating mutations or recom-
bination events necessary for viral fitness [59]. Genetic
and phylogenetic analyses using the whole-genome or
some individual genes have been conducted to deter-
mine diversity and relationships of global PEDV isolates.
Among these, the full-length S gene and its S1 portion
(aa 1–735) have been known to be suitable loci for
sequencing to investigate genetic relatedness and mo-
lecular epidemiology of PEDV [16, 26, 28, 60, 61].
Although only one serotype of PEDV has been reported,
phylogenetic studies of the S gene suggested that PEDV
can be genetically separated into 2 groups: genogroup 1
(G1; classical) and genogroup 2 (G2; field epidemic or
pandemic). Each genogroup can be further divided into
subgroups 1a and 1b, and 2a and 2b, respectively (Fig. 3).
G1a includes the prototype PEDV strain CV777, vaccine
strains, and other cell culture-adapted strains, whereas
G1b comprises new variants that were first identified in
China [9], later in the United States [62] and South
Korea [61], and recently in European countries [63–65].
G2 contains global field isolates, which are further clus-
tered into 2a and 2b subgroups responsible for previous
local epidemic outbreaks in Asia and recent pandemic
outbreaks in North America and Asia, respectively. The
global outbreak of virulent G2b strains appears to have
resulted from point mutations in resident virulent field
G1a populations.
S genes of most PEDV field strains within the G2
group consist of 4161 nucleotides (nt) encoding 1386
amino acid (aa) residues. These genes are 9-nt (3-aa)
longer than the homologous gene in the prototype
CV777 strain. Compared to the sequences of CV777, G2
PEDV strains possess distinct genetic signatures, S
insertions-deletions (S indels) that involve 2 notable 4-aa
and 1-aa insertions at positions 55 and 56 and positions
135 and 136, respectively, and a unique 2-aa deletion-
located between positions 160 and 161 within the N-
terminal hypervariable region of the S protein [26]
(Fig. 4). In addition, this S indel pattern in G2 strains is
identical to other novel G2 variants, MF3809 [Gen-
Bank:KF779469] and FL2013 [GenBank:KP765609],
identified in South Korea and China, respectively, which
harbored a large 204-aa S deletion at positions 713–916
or a 7-aa S deletion in the C-terminus, respectively
(Fig. 4) [66, 67].
New variant strains within G1b are genetically diver-
gent from G1a and G2 PEDV strains. Although G1b
strains were isolated from epidemic cases, they do not
contain genetic S signatures typical for G2 field strains.
Sequence comparison of the N-terminal one-third of the
S gene revealed that G1b strains share more than 95 %
of their sequence with G1a classical strains, but their
identity with G2 epidemic strains is less than 89 %. In
contrast, the analysis of the remaining portion of the S
gene indicated that G1b strains exhibit more than 99 %
identity with G2 field strains [61]. Furthermore, the en-
tire genome-based phylogenetic analysis showed that
G1b strains are clustered closely together with G2 epi-
demic PEDVs (Fig. 3b). Collectively, these data suggest
that novel G1b variants appear to have resulted from a
recombination event between classical G1a and epidemic
G2 viruses, possibly during viral sg mRNA transcription,
which most probably geographically happened in China.
The US G1b variants have been named S INDEL strains
because of the presence of insertions and a deletion in
the S gene compared to sequences of original US PEDV
strains [15]. This nomenclature might be incorrect since
genomic sequences of PEDV isolates should be initially
compared to that of the prototype PEDV strain CV777.
Considering this issue, all G2 epidemic isolates include
specific S indels, which make them different from
CV777. It is therefore recommended that those strains
be termed S INDEL strains.
Molecular epidemiology
Epidemiology of PEDV in Europe
Although PEDV first appeared in the United Kingdom
and spread to other European countries in the 1970s,
the disease impact caused by PEDV in Europe and its
economic importance were negligible compared to its
effects on the industry in Asian countries and the United
States. Over the last decades, therefore, the presence
of PEDV was not intensely studied. In 1980s and
1990s, PEDV outbreaks became infrequent, while the
virus persisted in an endemic form in the pig population
at a low rate. Sporadic outbreaks were reported in some
European countries, causing diarrhea in weaner or feeder
pigs. A number of serological surveys indicated that sero-
prevalence of PEDV had become low in European pigs
[68–73]. Interestingly, despite low immunity of pigs in
European countries, the virus has not been causing severe
outbreaks in these susceptible populations although the
exact resistance mechanism has not been elucidated.
However, PEDV that affected in pigs of all ages, in-
cluding suckling piglets, re-emerged in a typical epi-
demic form in Italy in 2006 [74]. In 2014, a case of
PED, which occurred on a fattening farm, was re-
ported in Germany [63]. Shortly thereafter, outbreaks
of PEDV were identified in a farrow-finish herd in
France and in fattening pigs in Belgium [64, 65].
These German, French, and Belgian PEDV strains
were found to be genetically almost identical to each
other (99.9 % identity) and most closely related to
G1b variants identified in China, the United States,
and South Korea (Fig. 3). Further surveillance studies
are needed to determine whether the G1b strains
have already been circulating in Europe or were
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recently introduced from the United States or Asia.
Since PED outbreaks may occur periodically in those
countries, the implementation of proper biosecurity
protocols would be necessary in order to prevent
further spread of PEDV domestically or internation-
ally in Europe. In addition, it would be important to
investigate if high virulent G2 PEDV is present in
certain areas of Europe.
Fig. 3 Phylogenetic analyses of global PEDV strains based on nucleotide sequences of the spike genes (a) and full-length genomes (b). A putative
similar region of the spike protein and the complete genome sequence of TGEV was included as an outgroup in each panel. Multiple sequence
alignments were performed using ClustalX 2.0 program and the phylogenetic tree was constructed from aligned nucleotide sequences using the
distance-based neighbor-joining method of MEGA5.2 software. Numbers at each branch represent bootstrap values greater than 50 % of 1000
replicates. Names of the strains, countries and years of isolation, GenBank accession numbers, genogroups, and subgroups are shown. PEDV
isolates identified in different countries are indicated by corresponding symbols: Europe (solid triangles), South Korea (sold circles), Thailand and
Vietnam, (sold diamonds), and the United States (solid squares). Scale bars indicate nucleotide substitutions per site
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Epidemiology of PEDV in Asia
In Asia, PED epidemics first occurred in 1982 in Japan
and since then, PED caused severe epidemics in adjacent
Asian countries, particularly in China and South Korea,
resulting in heavy losses of piglets [8, 11, 75]. In the late
2000s, PEDV has been reported and become increasingly
problematic in the Philippines, Thailand, Taiwan, and
Vietnam [10, 17, 76].
In Thailand, several outbreaks of severe PEDV infec-
tion have emerged since late 2007. PEDV isolates re-
sponsible for epidemics in Thailand had S genetic
signatures typical for field epidemic G2 strains and were
placed in the cluster adjoining to South Korean and
Chinese strains in the G2a or G2b subgroup ([77] see
also Fig. 3a). PED was first observed in southern prov-
inces of Vietnam and soon after, the disease spread
throughout all major swine-producing regions in that
country [76]. Vietnamese strains also had unique S indel
characteristics and could be classified as the G2b subli-
neage, which continues to cause sporadic outbreaks in
Vietnam [78].
PED still remains a devastating enteric disease leading
to serious losses in China since its first identification. In
the early 1990s, a vaccine containing the inactivated
prototype CV777 strain was developed and has since
been widely used throughout the swine industry in
China. Until 2010, outbreaks of PED became infrequent
with only a limited number of incidents. However, a
remarkable increase in PED epidemics occurred in pig-
producing provinces in late 2010 [9]. During that period,
new variants of PEDV belonging to the G1b genogroup
were first reported in China [9]. In addition, PED out-
breaks in vaccinated herds questioned the effectiveness
of the CV777-based vaccine [9]. Since then, severe
Fig. 4 Amino acid sequence alignment of the N-terminal region of the S protein of global PEDV strains. The top illustration represents the organization
of the PEDV genome. Only the corresponding alignment of amino acid sequences of the N-terminal region containing hypervariable regions [26] is
shown. Dashes (−) indicate deleted sequences. Potential N glycosylation sites predicted by GlycoMod Tool (http://www.expasy.ch/tools/glycomod/)
are shown in boldface type. Genetic subgroups of PEDV were marked with different colors: G1a (red), G1b (blue), G2a (green), and G2b (black). Insertions
and deletions (indels) within PEDV isolates compared to the prototype CV777 strain are shaded. Amino acids representing potential hypervariable
domains are indicated by solid boxes
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PEDV epidemics have been reported in various regions
in China [79–81]. At present, PED outbreaks in China
were caused by both G1b variants and field epidemic G2
strains that differed genetically from the prototype
CV777 strain [81]. One of the G2b strains, AH2012, was
later found to be a potential progenitor of US PEDV
strains that emerged subsequently during 2013 [15, 82].
Prior to late 2013, the prevalence of PEDV infection
was relatively low with only sporadic outbreaks in
Taiwan and Japan. In late 2013, severe large-scale PED
epizootics suddenly re-emerged in these countries,
which led to tremendous financial losses in their pork
industry [17, 18]. Taiwan and Japanese isolates during
2013 to 2014 were phylogenetically related to the same
clade as global G2b PEDV strains [17, 18].
Epidemiology of PEDV in the United States
PEDV has been exotic in the United States until its sud-
den and explosive emergence in May 2013. Since then,
PEDV has spread rapidly in swine farms across the
United States, causing significant financial losses [14].
Genetic and phylogenetic analyses of the emergent US
PEDV strains identified during the initial outbreak re-
vealed a close relationship with Chinese strains, espe-
cially the AH2012 strain isolated in 2012 from Anhui
Province in China, suggesting their origin [82]. Recently,
it was suggested that the emergent PEDV strains in the
United States potentially descended from 2 Chinese
strains, AH2012 [GenBank:KC210145] and CH/ZMDZY/
11 [GenBank:KC196276] in G2b sublineage through re-
combination [15, 80]. Furthermore, PEDV strains similar
to those found in the United States appear to be respon-
sible for subsequent large-scale PED outbreaks in South
Korea, Taiwan, and Japan in late 2013 [16–18].
In January 2014, other novel US PEDV strains, such as
OH851 [GenBank:KJ399978], without typical S protein
genetic signatures of the epidemic G2 virus were re-
ported. They phylogenetically clustered closely to novel
Chinese strains in the G1b subgroup based on the simi-
larities of the S gene or with the emergent US PEDV
strains in the G2 group based on the whole genome
characteristics [62]. Novel variants from the United
States had a low nucleotide identity in their first 1170
nucleotides of the S1 region and a high similarity in the
remaining S gene, compared to the PEDV strains mainly
circulating in the United States, suggesting a rapid evo-
lution of US PEDV variants through possible recombin-
ation events [62]. However, a retrospective study
demonstrated that the new US variants were already
present in June 2013, indicating a possibility that mul-
tiple parental PEDV strains were introduced into the
United States at about the same time [15]. Although
another PEDV variant TC-PC22A [GenBank:KM392224]
with a 197-aa deletion in the N-terminal region of the S
protein was isolated, the large deletion was found to
occur during cell adaptation, suggesting that such vari-
ants might not circulate naturally in US swine [50].
Epidemiology of PEDV in South Korea
The first PED epizootic in South Korea was confirmed
in 1992 [8]. However, a retrospective study revealed that
PEDV already existed since as early as 1987 [83]. PED
outbreaks have since occurred every year and became
endemic, which resulted in high rates of death among
piglets and substantial economic losses to domestic
swine industry until 2010. In a serological survey carried
out in 2007, 91.8 % of 159 tested farms had sero-positive
pigs in wean to finish periods (30–150 days of age), indi-
cating that the majority of farms were affected with en-
demic PEDV infection [84]. Since early 2000s, both
modified attenuated and inactivated vaccines based on
domestic isolates SM98-1 or DR-13 have been intro-
duced nationwide, leading to a decline in the incidence
of PEDV-associated diarrheal disease outbreaks com-
pared to the past years. However, continuous PED epi-
demics in vaccinated farms have raised problems related
to the efficacy of Korean commercial vaccines. PED iso-
lates, which prevalently circulated in South Korea during
the same period, were classified as G2a strains that con-
tained S indels compared to CV777 and were distantly
related to CV777 or Korean vaccine strains belonging to
the G1a subgroup [26].
After South Korea experienced severe outbreaks of the
foot-and-mouth disease (FMD) in 2010–2011, there was
a state of lull during PED emergence. The prevalence of
PEDV infections was occasional with only intermittent
outbreaks in South Korea from 2011 to early 2013. This
epidemic situation likely resulted from the mass culling
of more than 3 million pigs (one-third of the entire
domestic pig population) in South Korea during the
2010–2011 FMD outbreaks. However, beginning from
November 2013, severe PED epidemics increased re-
markably and swept through more than 40 % of pig
farms across mainland South Korea [16]. Four months
later, PEDV hit Jeju Island, which was PEDV-free since
2004 [60]. The re-emergent PEDV isolates responsible
for massive epidemics in South Korea in 2013–2014
were classified into the G2b subgroup, where they clus-
tered closely with emergent US PEDV strains [16, 60].
The source of PEDV incursion into the South Korean
swine population has not yet been determined. The im-
portation of pig breeding stock during or after the sud-
den emergence of PEDV in the United States might be
one of the possible sources, but it remains unclear
whether G2b PEDVs similar to US strains had pre-
existed in South Korea. Indeed, the G2b isolates
KDJN12YG [GenBank:KJ857475] and KNU-1303 [Gen-
Bank:KJ451038] have been identified independently in
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November 2012 [59] and May 2013 [16], respectively.
The former was similar to Chinese G2b strains, whereas
the latter resembled emergent US G2b strains (Fig. 3a).
Given these results, it is also conceivable that the virus,
which has evolved independently by recombination or
point mutations might have already been present in
South Korea as a minor lineage before the emergence of
outbreaks in the United States. Alternatively, it might
have originated directly from China. Under suitable cir-
cumstances, G2b strains have subsequently become
dominant, leading to a number of recent acute outbreaks
nationwide [16, 59].
In March of 2014, novel variant G1b PEDV isolates
have been found in South Korea, which were similar to
the variants reported in China, the United States, and
recently in several European countries [61]. They had
common genetic and phylogenetic features of G1b
strains (no S indels compared to CV777, different phylo-
genetic subgroup [G1b or G2] depending on the se-
quence of the S protein or whole-genome, and evidence
of recombination), and were most closely related to the
US variant strain OH851 among other G1b strains [61].
Although a temporal study will be needed to verify the
presence of the G1b virus in earlier periods before its
first identification, it is possible that similar to the causes
of outbreaks in the United States, 2 G1b and G2b ances-
tor strains resembling US strains could have been simul-
taneously transmitted into South Korea. Another novel
PEDV G2 strain (MF3809) with a large S deletion was
found in South Korea, however, this isolate was identi-
fied from only 3 diarrhea samples out of 2634 on 1 out
of 569 farms obtained in 2008 [66]. Thus, probability of
the existence of this variant in South Korean pigs is very
low at present. Nonetheless, we need to continue sur-
veying yet-unidentified PEDV variants that may emerge
locally or globally through genetic drift (e.g., after point
mutations) or genetic shift (e.g., recombination events).
Transmission
PEDV infection among pigs occurs principally by a dir-
ect or indirect fecal-oral route. Airborne transmission
may also play a role in PEDV dissemination under cer-
tain conditions [85]. PEDV can mainly enter farms by
diarrheal feces or vomitus and contaminated environ-
mental sources via clinically or subclinically infected
pigs, trailers (transporting pigs, manures, or food),
people (pig owners or visitors, such as swine practi-
tioners or trailer drivers in contaminated work clothing
and footwear), or wild animals and birds [6, 86]. Other
contaminated fomites, such as sow milk, feed, food
items, or food additives or ingredients, including spray-
dried porcine plasma, could all be potential sources of
the virus [9, 87–89].
After an acute (epidemic) outbreak, PEDV may dis-
appear, remain in the farrowing unit because of inad-
equate hygiene management (e.g., improper disinfection
and poor biosecurity), or persist in pigs in weaning or
growing-finishing units where the virus is circulating,
causing mild post-weaning diarrhea with very low mor-
tality rates. In this endemic status, if newly born pigs are
unable to obtain sufficient levels of maternal immunity
from their dams due to incomplete sow vaccination or
defective lactation performance owing to mastitis or
agalactia, the virus circulating on the farm will infect sus-
ceptible piglets, which serve as the source of recurrence of
epidemic outbreaks leading to a high number of pig
deaths [90, 91]. Such endemic PED circumstances are not
restricted to Asia: they may equally happen in North
America, where sudden PED epidemics recently emerged.
Clinical signs, lesions, and pathogenesis
PEDV can infect pigs of all ages, causing watery diarrhea
and vomiting accompanied by anorexia and depression.
Morbidity approaches 100 % in piglets, but can vary
in sows [6]. The incubation period of PEDV is ap-
proximately 2 days, ranging from 1 to 8 days depend-
ing on field or experimental conditions. The interval
between the onset and cessation of clinical signs is
3–4 weeks [4, 6, 49, 81, 92, 93]. Fecal shedding of
PEDV can be detected within 48 h and may last for
up to 4 weeks. The severity of the disease and mor-
tality rates might be inversely associated with the age
of the pigs [6, 94]. PEDV infection in piglets up to
1 week of age causes severe watery diarrhea and
vomiting for 3–4 days followed by extensive dehydra-
tion and electrolyte imbalance leading to death. Mor-
tality rate averages 50 %, often approaching 100 % in
1- to 3-day-old piglets, and decreases to 10 % there-
after. In older animals, including weaner to finisher
pigs, clinical signs are self-limiting within 1 week
after the onset of the disease. However, PED may
affect growth performance of growing pigs. Sows may
not have diarrhea and often they manifest depressive
symptoms and anorexia. If farrowing sows lose their
offspring, they may subsequently suffer from repro-
ductive disorders including agalactia or delayed estrus,
which result from the absence of suckling piglets
during the lactation period.
Gross lesions are confined to the gastrointestinal
tract and characterized by distended stomach filled
with completely undigested milk curd and thin, trans-
parent intestine walls with accumulation of yellowish
fluids [49, 92, 95]. Histological hallmarks of the PEDV
infection include severe diffuse atrophic enteritis, superfi-
cial villous enterocyte swelling with mild cytoplasmic
vacuolation, necrosis of scattered enterocytes followed by
sloughing, and contraction of the subjacent villous lamina
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propria containing apoptotic cells [49, 92, 93, 95]. The
intestinal villi become reduced to two-thirds or more of
their original length (villous height to crypt depth ratios
change to less than 3:1 in affected pigs) with the extent of
the pathology depending on the stage of the infection or
disease process [92, 93, 95].
PEDV replicates in the cytoplasm of villous epithelial
cells throughout the small intestine, destroying target
enterocytes as a result of massive necrosis or apoptosis.
These processes lead to villous atrophy and vacuolation
as well as a marked reduction in the enzymatic activity
[6, 55]. This sequence of events interrupts digestion and
absorption of nutrients and electrolytes, thereby causing
malabsorptive watery diarrhea followed by serious and
fatal dehydration in piglets [6, 96]. Upon infection with
PEDV, the disease outcome and deaths usually occur
age-dependently. Although the reasons why PEDV
causes more severe disease in nursing piglets in com-
parison to weaned pigs have not been clearly elucidated,
slower regeneration of enterocytes in neonatal pigs may
an important factor [97]. PEDV infection increases the
number of crypt stem cells and proliferation of crypt
cells, pointing to the accelerated epithelial cell renewal
[98]. Enterocyte turnover rate was slower in normal
nursing piglets than in weaned pigs, suggesting that the
speed of crypt stem cell replacement appears to be asso-
ciated with the age-dependent resistance to PED [98].
Diagnosis
Since signs of the PEDV infection were clinically and
pathologically indistinguishable from those caused by
TGEV and the recently described porcine deltacorona-
virus [96, 99, 100], PED diagnosis cannot be made purely
on the basis of clinical signs and histopathological le-
sions. Therefore, differential diagnosis to demonstrate
the presence of PEDV and/or its antigens must be con-
ducted in the laboratory. A variety of PEDV detection
methods, which include immunofluorescence (IF) or
immunohistochemistry (IHC) tests, in situ hybridization,
electron microscopy, virus isolation, enzyme-linked
immunosorbent assays (ELISA), and various reverse-
transcription polymerase chain reaction (RT-PCR) tech-
niques, have been used. Taking into account their fast
turnaround times and sensitivity, conventional and real-
time RT-PCR systems available as commercial kits are
most widely used for PEDV detection during epidemic
or endemic outbreaks, as well as for quarantine or
slaughter policies. In addition, nucleotide sequencing of
the S gene region may be useful in determining the
genotype of PEDV circulating in herds. The combination
of RT-PCR and S gene sequencing could well become
the optimal tool for monitoring genetic diversity among
PEDV isolates.
A number of serological assays have been used for the de-
tection of PEDV antibodies, including indirect fluorescent
antibody (IFA) staining, ELISA, and virus neutralization
(VN) tests. Due to the special protection strategy (passive
immunization) for neonatal piglets against PEDV, deter-
mining the presence or absence of anti-PEDV antibodies
may be meaningless in sow herds. Instead, measuring quan-
tities (or titers) of neutralizing antibodies against PEDV or,
especially, against the S protein in serum and colostrum
should be necessary to monitor the immunity level follow-
ing sow immunization. In this regard, VN test could be
essential for estimating levels of protective antibodies,
which piglets would receive from sows. However, this
method is time-consuming and cannot selectively detect
only secretory IgA antibodies representing mucosal im-
munity. In contrast, IFA and indirect ELISA approaches for
antibody detection are equally specific but less time-
consuming and easier to perform than VN test. Most assays
that are currently in use have been developed on the basis
of either whole virus [101–103] or viral protein antigens
[29, 104]. Whole virus-based IFA and ELISA tests may be
inappropriate for detecting protective antibodies regardless
of the antigen (S, M, or N proteins) since they can only
detect exposure due to natural infection or vaccination.
However, these tools may still be useful for monitoring
endemic situation with the PEDV infection in affected
farms by determining infection status in weaner to finisher
pigs. On the other hand, the entire S protein or its S1 por-
tion could be used as viral antigens for developing ELISA
because the S1 domain has been reported to contain the
receptor binding region and main neutralizing epi-
topes [45, 105]. Recently, a recombinant S1 protein-
based indirect ELISA has been developed to detect
anti-PEDV antibodies [29]. Although this method is a use-
ful, sensitive and specific tool for the detection of anti-
PEDV S IgG and IgA antibodies in serum and colostrum
samples, it remains to be determined whether concentra-
tions of these antibodies correlate with levels of immune
protection.
Prevention and control measures
Biosecurity
One of the most important measures for prevention and
control of acute PED outbreaks is strict biosecurity that
blocks in principle the entrance of PEDV into pig farms
(fattening and farrowing units) by minimizing introduc-
tion of any material or any person, which could be in
contact with the virus. To accomplish this, disinfection
must be thoroughly applied to all fomites, personnel,
and external visitors that could be contaminated with
PEDV. Although PEDV is inactivated by most virucidal
disinfectants [24], PEDV RNA can still be detected by
RT-PCR even after disinfection with several commer-
cially available disinfectants [106]. Thus, we may need to
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evaluate disinfectants in vivo or under various field con-
ditions, especially during the winter season, in order to
select suitable disinfectant compositions and appropriate
procedures. The following order of disinfection steps is
recommended to pork producers attempting to disinfect
transportation equipment or affected farrowing units: (i)
proper cleaning by a high pressure washer using warm
water at temperatures over 70 °C; (ii) disinfection by an
appropriate disinfectant according to directions on the
label; and (iii) overnight drying [90, 91]. Other biosecur-
ity measures include restricting human traffic between
fattening and farrowing units and limiting contact be-
tween trailers or drivers and the farm interior during the
loading process at the pig farm or between drivers and
the slaughter facilities during the unloading process at
the collection point [86, 90, 91]. All newly arriving or re-
placement animals including gilts should be isolated for
a certain period to monitor their health status [90, 91].
PEDV is a transboundary virus that seems to spread
readily to neighboring or distant countries even across
continents. Since PEDV is not a World Organization for
Animal Health reportable disease, quarantine inspection
might not properly implement potential sources or
routes that mediate virus transmission between coun-
tries. During large-scale severe PED epidemics in adja-
cent or trading countries, quarantine (or international
biosecurity) procedures should be adequately reinforced
with a particular attention to any risk factors of inter-
national disease transmission in order to prevent the
entrance of PEDV as well as other emerging or re-
emerging pathogens. On the basis of available genetic
and phylogenetic data on global PEDV strains, I propose
several prospective paths through which PEDV could
have spread to Asia and North America (Fig. 5). The
classical G1a isolates might have emerged in China due
to a careless use of cell-adapted strains as autogenous
vaccines or illegal importation of attenuated live vaccines
from South Korea. The epidemic G2a South Korean
strains might have been initially introduced into China.
Chinese G2a viruses were later transmitted to Southeast
Asian countries including Thailand and Vietnam. It is
also possible that G2a strains in these countries could
have been directly transported from South Korea. In
China, novel classical G1b and pandemic G2b viruses
appear to have arisen concurrently in late 2010 to early
2011 probably via recombination between local G1a and
G2a strains or point mutations in resident G2a viruses,
respectively. These strains were likely coincidentally in-
troduced into the United States. US-like G1b and G2b
strains later landed in South Korea. The genesis of epi-
demic G2b strains might be ascribed to the evolutionary
drift in local G2a lineages in South Korea. In addition,
US-like G2b viruses spread further to other North
American countries and also to Taiwan and Japan. Cur-
rently, there have been no official reports about the
emergence of G1b viruses in these countries. Novel G1b
and G2b strains may already be present in or they may
yet to be brought to Southeast Asian countries from
Fig. 5 Potential international PEDV transmission routes. Genetic subgroups of PEDV were marked with different colors as described in the legend
to Fig. 4. Solid lines indicate PEDV spreads that have already occurred between countries; dotted lines indicate PEDV spreads that are expected to
happen eventually; dashed circular arrows denote genetic mutations or recombination events that lead to the emergence of the novel subtypes
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China or South Korea. Considering this expected inter-
national dissemination route, we may recheck the im-
portance of quarantine policy against PEDV and other
epizootic agents.
Vaccines
Vaccination of sows is a fundamental tool in a strategy
to control and eradicate PED during epidemic or en-
demic outbreaks. Piglets are then protected by a transfer
of maternal antibodies via colostrum and milk from im-
mune dams. Although PED first emerged in Europe, the
disease has not caused sufficient economic losses to jus-
tify the vaccine development. In contrast, PED outbreaks
in Asian countries have been serious, and therefore sev-
eral PEDV vaccines have been developed. In China,
CV777-attenuated or -inactivated vaccines have been
routinely applied against PED. Attenuation of the viru-
lence of the Japanese PEDV strain 83P-5 was achieved
after 100 passages in Vero cells [27]. Subsequently, the
cell-adapted 83P-5 strain has been employed as an intra-
muscular (IM) live virus vaccine (P-5 V) in Japan and it
is now also available in South Korea. The cell-culture
adaptation method was also applied to attenuate two
South Korean virulent PEDV strains, SM98-1 (93 pas-
sages) and DR-13 (100 passages) [107, 108]. The SM98-1
strain has been used as an IM live or killed vaccine,
whereas DR-13 is available as an oral live vaccine. Al-
though these attenuated or inactivated vaccines have
been demonstrated to provide protection under experi-
mental conditions, their effectiveness in the field, as well
as pros and cons of their use, are still being debated. In
South Korea, the multiple dose vaccination program (3
or 4 IM administrations of vaccines in the following
order: live-killed-killed or live-live-killed-killed, corres-
pondingly) at 2- or 3-week intervals starting before far-
rowing or mating is commonly recommended in
pregnant sows or gilts to maintain high levels of neutral-
izing antibodies in serum and colostrum [90, 91].
Recently, the Korean Animal and Plant Quarantine
Agency evaluated the efficacy of domestic and imported
PED vaccines commercially available in South Korea.
The administration of each commercial vaccine accord-
ing to corresponding manuals (twice at both 3 and
5 weeks prior to farrowing) increased the survival rate of
piglets challenged with a virulent wild-type PEDV from
18.2 % to over 80 %. However, all vaccines did not sig-
nificantly reduce the morbidity rate of diarrhea including
virus shedding in feces [109]. Although protection
against the enteric disease is primarily dependent on the
presence of secretory IgA antibodies in the intestinal
mucosa, the vaccine efficacy might be associated with
maintaining high levels of PEDV-specific neutralizing
antibodies in the serum and colostrum of vaccinated
sows [90, 91, 109]. In addition to a direct vaccination,
another crucial aspect is passive colostral and lactogenic
immunity of neonatal piglets by ample quantities of pro-
tective antibodies obtained from sow colostrums and
milk. Thus, sanitation and health conditions of lactating
sows have to be monitored to eliminate potential factors
negatively affecting lactation performance, such as mas-
titis or agalactia, so that sows could constantly provide
high-quality colostrum and milk to their litters. Suckling
piglets lose their source of lactogenic immunity at wean-
ing and soon thereafter become vulnerable to PEDV.
Following an acute PED epidemic, the virus may persist
in susceptible animals or pigs that survived, leading to
the circulation of the virus on the farm (endemic PED).
Thus, active immunization of weaner to finisher pigs
may be necessary for the control of endemic PEDV
infections [6].
The low to moderate effectiveness of current PEDV
vaccines appears to be due to antigenic, genetic (>10 %
amino acid variation between respective S proteins) and
phylogenetic (G1 vs. G2) differences between vaccine
and field epidemic strains [16, 26, 30, 49, 59]. Therefore,
G2b epidemic PEDV or related strains prevalent in the
field should be used for the development of next gener-
ation vaccines to control PED. The recombinant S1 pro-
tein derived from the field G2 PEDV isolate efficiently
protected newborn piglets against PEDV, so it could be
potentially used as a subunit vaccine for PED prevention
in the future [30]. Isolation of PEDV that is phenotypic-
ally and genotypically identical to field strains respon-
sible for PED epidemics worldwide is critical for
developing effective vaccines. A number of culturable
PEDV strains associated with recent outbreaks were ob-
tained in the United States [28, 50]. On the basis of
these isolates, an inactivated PEDV vaccine has been
developed, which is currently available on the US mar-
ket. It is expected that commercial live attenuated vac-
cines will soon be ready for pig producers. In South
Korea, a field epidemic PEDV strain has been recently
isolated in my laboratory, and we are now utilizing this
isolate to spur the development of new effective and safe
vaccines [49]. Interestingly, a recent study indicated that
previous exposure of sows with “mild” G1b PEDV pro-
vides cross-protective lactogenic immunity against piglet
challenge with virulent G2b virus [110]. This finding
suggests that the vaccine or route of administration may
also affect the efficacy of vaccines. Although it may be
hard to predict the efficacy of new vaccines in the field,
they will be promising practical tools for prevention
and/or control of PED if their use is accompanied by
tightened biosecurity and optimal farm management.
Alternative immunoprophylactic and therapeutic strategies
In acute PED outbreaks with rapidly increasing mortality
rates, we may consider intentional exposure (feedback)
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of pregnant sows to the autogenous virus using watery
feces or minced intestines from infected neonatal piglets,
which will artificially stimulate rapid lactogenic immun-
ity and, hopefully, shorten the outbreak on the farm [6].
However, there are several complications that need to be
considered before the application of this approach.
Wide-spread circulation of other viral pathogens, such as
PRRSV or PCV2, contained in the intestinal or fecal con-
tents may occur among sows or piglets [111, 112]. Since
autogenous viral materials do not have homogenous infec-
tious titers of PEDV, sow immunity may not be induced to
a level sufficient for offspring protection. Following artifi-
cial exposure of sows, infectious viruses will be shed in
feces, which, in turn, could be a potential source for PEDV
transmission within the contaminated establishment and
between different farms.
Artificial passive immunization by oral administration of
specific antibodies represents an attractive approach
against gastrointestinal pathogens such as PEDV. Chicken
egg yolk immunoglobulin against PEDV or the S1 domain
has been found to protect neonatal piglets following chal-
lenge exposure [113, 114]. The immunoprophylactic effect
of colostrum from cows immunized with PEDV has also
led to a reduced mortality in newborn piglets [115]. Single
chain variable fragments (scFvs) of the mouse monoclonal
antibody or E. coli expressing scFvs were verified to
neutralize PEDV in vitro [116]. This suggests that recom-
binant E. coli harboring scFvs might be an alternative
prophylactic measure against PEDV infection. Pharmaco-
logical, biological, or natural agents that shorten epithelial
cell renewal by stimulating proliferation or reorganization
of crypt stem cells could be potential therapeutic targets to
reduce PEDV-associated mortality from dehydration fol-
lowing severe villous atrophy [98]. For instance, the epider-
mal growth factor (EGF) has been shown to stimulate
proliferation of intestinal crypt epithelial cells and to miti-
gate atrophic enteritis induced in piglets by PEDV infec-
tion. This finding suggested that treatment with EGF could
be another therapeutic option [117]. Broad-spectrum anti-
viral drugs, such as ribavirin, which suppress PEDV infec-
tion in vitro, are of interest for their potential to treat PED
[53]. Chemical inhibitors as well as compounds from medi-
cinal plants or natural sources, which block the activation
of mitochondrial AIF or MAPK signaling pathways re-
quired for PEDV replication, could be new therapeutic
candidates to reduce PEDV-associated symptoms and mor-
tality [55, 56]. In addition, nutritional supplements, which
reduce stress and enhance resistance to the disease, may be
useful for PED control in neonatal piglets.
Conclusions
For the last two or three decades, PED has continued to
plague the pork industry in Europe and Asia. In early
2013, the disease struck North America resulting in
great economic losses, especially in the United States.
Shortly thereafter, massive nationwide PED outbreaks
reoccurred in South Korea, Japan, and Taiwan. PED is
now globally recognized as an emerging and re-emerging
disease and it has become a major financial issue for the
swine industry worldwide. Despite geographically limited
PED studies in Europe and Asia, a better knowledge of
the virology, pathogenesis, immunology, epidemiology,
and vaccinology has been gained. Since the emergence of
PED in North America, much has been learned from
research in the United States. Nevertheless, further studies
are warranted to decipher the virus and the associated dis-
ease, and more extensive academic and practical studies
are needed for a comprehensive understanding of the
molecular and pathogenic biology of PEDV in order to
develop effective vaccines and establish control measures
including biosecurity in affected areas. Lastly, we should
bear in mind that a combined application of vaccines, bio-
security protocols, and husbandry management must be
the key step to prevent and control PED. Integrated and
coordinated efforts in various disciplines among re-
searchers, swine veterinarians, producers, swine industry
specialists, producer associations, and authorities are
required to achieve effective implementation of necessary
measures.
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